Raymond James Financial Maintains Skyworks Solutions (NDAQ:SWKS) As Outperform; Has Price Objective Of $120.00, 4 Analysts Covering Blueprint Medicines (BPMC)

June 19, 2017 - By Kurt Siggers

Among 9 analysts covering Skyworks Solutions Inc. (NDAQ:SWKS), 9 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Skyworks Solutions Inc. has $120 highest and $108 lowest target. $114.71’s average target is 12.57% above currents $101.9 stock price. Skyworks Solutions Inc. had 10 analyst reports since March 8, 2017 according to SRatingsIntel. On Friday, June 16 the stock rating was maintained by Raymond James with “Outperform”. On Friday, April 28 the stock rating was maintained by Drexel Hamilton with “Buy”. Craig Hallum maintained Skyworks Solutions Inc (NASDAQ:SWKS) on Tuesday, April 4 with “Buy” rating. The firm earned “Buy” rating on Friday, April 28 by Canaccord Genuity. The rating was upgraded by Pacific Crest on Tuesday, April 4 to “Overweight”. As per Friday, April 28, the company rating was maintained by Craig Hallum. The stock of Skyworks Solutions Inc (NASDAQ:SWKS) has “Outperform” rating given on Friday, March 31 by Macquarie Research. The firm has “Outperform” rating given on Wednesday, March 8 by Wells Fargo. Needham maintained Skyworks Solutions Inc (NASDAQ:SWKS) rating on Friday, April 28. Needham has “Buy” rating and $108 target.

Among 4 analysts covering Blueprint Medicine Corp (NASDAQ:BPMC), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Blueprint Medicine Corp had 5 analyst reports since February 22, 2016 according to SRatingsIntel. The rating was upgraded by Goldman Sachs to “Buy” on Monday, March 13. The stock of Blueprint Medicines Corp (NASDAQ:BPMC) earned “Buy” rating by Canaccord Genuity on Friday, August 5. The firm has “Outperform” rating by Raymond James given on Friday, May 27. The rating was maintained by JMP Securities with “Market Outperform” on Wednesday, March 9. See Blueprint Medicines Corp (NASDAQ:BPMC) latest ratings:

13/03/2017 Broker: Goldman Sachs Old Rating: Neutral New Rating: Buy Upgrade

Skyworks Solutions Inc. designs, develops, makes and markets semiconductor products, including intellectual property. The company has market cap of $18.73 billion. The Company’s analog semiconductors are connecting people, places, and things, spanning a number of new and unimagined applications within the automotive, broadband, cellular infrastructure, connected home, industrial, medical, military, smartphone, tablet and wearable markets. It has a 21.01 P/E ratio. The Company’s geographical divisions include the United States, Other Americas, China, Taiwan, South Korea, Other Asia-Pacific, Europe, Middle East and Africa.

Since January 17, 2017, it had 0 insider buys, and 11 insider sales for $17.91 million activity. GAMMEL PETER L sold $116,460 worth of stock. 18,250 shares were sold by GRIFFIN LIAM, worth $1.86 million on Thursday, May 11. $324,131 worth of Skyworks Solutions Inc (NASDAQ:SWKS) was sold by TERRY ROBERT JOHN. The insider ALDRICH DAVID J sold $4.84M. $315,434 worth of stock was sold by GASPARINI LAURA A on Monday, January 30. KING CHRISTINE sold $380,940 worth of stock.

The stock decreased 0.37% or $0.38 during the last trading session, reaching $101.9. About 26 shares traded. Skyworks Solutions Inc (NDAQ:SWKS) has risen 65.40% since June 19, 2016 and is uptrending. It has outperformed by 48.70% the S&P500.

Analysts await Skyworks Solutions Inc (NASDAQ:SWKS) to report earnings on July, 20. They expect $1.42 earnings per share, up 23.48% or $0.27 from last year’s $1.15 per share. SWKS’s profit will be $261.01 million for 17.94 P/E if the $1.42 EPS becomes a reality. After $1.33 actual earnings per share reported by Skyworks Solutions Inc for the previous quarter, Wall Street now forecasts 6.77% EPS growth.

Investors sentiment decreased to 0.91 in 2016 Q4. Its down 0.08, from 0.99 in 2016Q3. It dived, as 61 investors sold Skyworks Solutions Inc shares while 221 reduced holdings. 85 funds opened positions while 172 raised stakes. 149.94 million shares or 1.15% more from 148.24 million shares in 2016Q3 were reported. Cambridge Inv Rech Advisors holds 12,855 shares or 0.02% of its portfolio. Banced holds 1.53% or 10,847 shares in its portfolio. The Massachusetts-based Putnam Invests Lc has invested 0.01% in Skyworks Solutions Inc (NASDAQ:SWKS). Koshinski Asset Mgmt accumulated 0% or 5,154 shares. 3,361 are held by Gofen Glossberg Llc Il. Monetary has invested 0.01% of its portfolio in Skyworks Solutions Inc (NASDAQ:SWKS). Goodman Fincl Corporation holds 2.78% or 66,537 shares. Moreover, Hodges Mngmt Incorporated has 0.04% invested in Skyworks Solutions Inc (NASDAQ:SWKS). Mufg Americas owns 1,300 shares. Yhb Inc has 4,520 shares. 3,260 were accumulated by Hancock Holding. Callahan Advisors Limited Liability Company has invested 1.35% in Skyworks Solutions Inc (NASDAQ:SWKS). Fin Professionals invested in 53 shares or 0% of the stock. 12,287 are owned by Jaffetilchin Inv Partners Limited Liability Company. Petrus Com Lta holds 0.05% of its portfolio in Skyworks Solutions Inc (NASDAQ:SWKS) for 2,858 shares.

The stock increased 2.36% or $0.92 on June 16, reaching $39.9. About shares traded. Blueprint Medicines Corp (NASDAQ:BPMC) has risen 128.96% since June 19, 2016 and is uptrending. It has outperformed by 112.26% the S&P500.

Blueprint Medicines Corporation is a biopharmaceutical company. The company has market cap of $1.59 billion. The Firm focuses on patients with genomically defined diseases driven by abnormal kinase activation. It currently has negative earnings. It focuses on crafting drug candidates that provide clinical responses to patients without adequate treatment options.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: